Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Ma

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
ESMO Open|October 5, 2024
Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinomaT S A Kwong, H S Leung, F K F Mo, et al.
Investigational New Drugs|May 15, 2010
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaEdwin Pun Hui, Vivian W Y Lui, Cesar S C Wong, et al.
European Radiology|August 27, 2024
Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinomaQi Yong H Ai, Ann D King, Yip Man Tsang, et al.
Cancer Biology & Therapy|March 20, 2014
Characterization of rare transforming KRAS mutations in sporadic colorectal cancerJoanna H M Tong, Raymond W M Lung, Frankie M C Sin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2007
Adjuvant chemoradiation for gastric cancer: experience in the Chinese populationW K Tsang, S F Leung, S K W Chiu, et al.
Nature Reviews. Clinical Oncology|July 1, 2021
Nasopharyngeal carcinoma: an evolving paradigmKenneth C W Wong, Edwin P Hui, Kwok-Wai Lo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphismsB B Y Ma, E P Hui, S C C Wong, et al.
Investigational New Drugs|September 17, 2009
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of responseBrigette B Y Ma, Vivian W Y Lui, Fan Fong Poon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative StudyEdwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Cancer Research|January 26, 2013
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patientsEdwin P Hui, Graham S Taylor, Hui Jia, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
ESMO Open|October 5, 2024
Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinomaT S A Kwong, H S Leung, F K F Mo, et al.
Investigational New Drugs|May 15, 2010
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaEdwin Pun Hui, Vivian W Y Lui, Cesar S C Wong, et al.
European Radiology|August 27, 2024
Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinomaQi Yong H Ai, Ann D King, Yip Man Tsang, et al.
Cancer Biology & Therapy|March 20, 2014
Characterization of rare transforming KRAS mutations in sporadic colorectal cancerJoanna H M Tong, Raymond W M Lung, Frankie M C Sin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2007
Adjuvant chemoradiation for gastric cancer: experience in the Chinese populationW K Tsang, S F Leung, S K W Chiu, et al.
Nature Reviews. Clinical Oncology|July 1, 2021
Nasopharyngeal carcinoma: an evolving paradigmKenneth C W Wong, Edwin P Hui, Kwok-Wai Lo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphismsB B Y Ma, E P Hui, S C C Wong, et al.
Investigational New Drugs|September 17, 2009
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of responseBrigette B Y Ma, Vivian W Y Lui, Fan Fong Poon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative StudyEdwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Cancer Research|January 26, 2013
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patientsEdwin P Hui, Graham S Taylor, Hui Jia, et al.
Pageof 15